UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

The New England journal of medicine, 2020-12, Vol.383 (23), p.2207-2218

2020

Link zum Volltext

Verfügbarkeit prüfen

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study

Clinical cancer research, 2016-04, Vol.22 (7), p.1572-1582

2016

Link zum Volltext

Verfügbarkeit prüfen

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy

Nature communications, 2017-12, Vol.8 (1), p.2185-12, Article 2185

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE‐013

British journal of haematology, 2019-08, Vol.186 (3), p.e41-e44

2019

Link zum Volltext

Verfügbarkeit prüfen

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia

JAMA dermatology (Chicago, Ill.), 2016-06, Vol.152 (6), p.698

2016

Link zum Volltext

Verfügbarkeit prüfen

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy

Clinical cancer research, 2016-01, Vol.22 (1), p.86-95

2016

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study

British journal of haematology, 2019-09, Vol.186 (5), p.e117-e121

2019

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

Haematologica (Roma), 2015-12, Vol.100 (12), p.1571-1578

2015

Link zum Volltext

Verfügbarkeit prüfen

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Blood, 2015-11, Vol.126 (19), p.2213-2219

2015

Link zum Volltext

Verfügbarkeit prüfen

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Blood, 2017-03, Vol.129 (11), p.1469-1479

2017

Link zum Volltext

Verfügbarkeit prüfen

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood

Leukemia, 2017-06, Vol.31 (6), p.1340-1347

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease

Diabetology and metabolic syndrome, 2023-11, Vol.15 (1), p.1-229, Article 229

2023

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e448-e458

2019

Link zum Volltext

Verfügbarkeit prüfen

Pneumonia and concealed pulmonary embolism: A case report and literature review

The Journal of the Royal College of Physicians of Edinburgh, 2022-06, Vol.52 (2), p.142-146

2022

Link zum Volltext

Verfügbarkeit prüfen

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

JAMA oncology, 2016-12, Vol.2 (12), p.1656

2016

Link zum Volltext

Verfügbarkeit prüfen

Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience

Contemporary clinical trials, 2020-12, Vol.99, p.106179-106179, Article 106179

2020

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma

Cancer discovery, 2024-01, Vol.14 (1), p.66

2024

Link zum Volltext

Verfügbarkeit prüfen

NOVEL CLINICAL MANIFESTATION OF VARIANT SCN5A GENE

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1255-1255

2016

Link zum Volltext

Verfügbarkeit prüfen

Wernicke's encephalopathy in an adolescent following bariatric surgery

Journal of pediatric surgery case reports, 2023-01, Vol.88, p.102525, Article 102525

2023

Link zum Volltext

Verfügbarkeit prüfen

Intercalated Disk Extracellular Nanodomain Expansion in Patients With Atrial Fibrillation

Frontiers in physiology, 2018-05, Vol.9, p.398-398

2018

Link zum Volltext

Verfügbarkeit prüfen

INCREMENTAL DEEP NEURAL NETWORK INTRUSION DETECTION IN FOG BASED IOT ENVIRONMENT: AN OPTIMIZATION ASSISTED FRAMEWORK

Indian journal of computer science and engineering, 2021-12, Vol.12 (6), p.1847-1859

2021

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

International journal of hematology, 2020-11, Vol.112 (5), p.640-649

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(198)
Mit Volltextzugriff
(221)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(99)
Humans
(55)
Male
(52)
Aged
(34)
Female
(34)
Hematology
(31)
Middle Aged
(30)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(26)
Oncology
(25)
Animals
(21)
Adult
(20)
Rats
(16)
Aged, 80 And Over
(15)
Chronic Lymphocytic Leukemia
(15)
Physical Sciences
(14)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(13)
Rats, Inbred Strains
(13)
Toxicology
(13)
Pharmacology & Pharmacy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy

Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE‐013

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia

Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy

Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood

Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Pneumonia and concealed pulmonary embolism: A case report and literature review

Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib

Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience

First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma

NOVEL CLINICAL MANIFESTATION OF VARIANT SCN5A GENE

Wernicke's encephalopathy in an adolescent following bariatric surgery

Intercalated Disk Extracellular Nanodomain Expansion in Patients With Atrial Fibrillation

INCREMENTAL DEEP NEURAL NETWORK INTRUSION DETECTION IN FOG BASED IOT ENVIRONMENT: AN OPTIMIZATION ASSISTED FRAMEWORK

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

Suchergebnisse filtern